Analysis of Human Uniparental Embryonic Stem Cells Reveals New Putative Imprinted Loci

Abstract

Genomic imprinting, an epigenetic process resulting in parent-specific gene expression, is essential for normal development and growth. Disruption of imprinting leads to various developmental disorders and cancers, yet our understanding of the full repertoire of imprinted genes in humans remains incomplete. Here, we utilised androgenetic, parthenogenetic and biparental human embryonic stem cells and their neural derivatives to identify novel imprinted genes by analysing their methylome and transcriptome profiles. Our analysis revealed 12 novel putative imprinted genes distributed across four distinct loci, with six of them clustered in an uncharacterised imprinted region on chromosome 19. We identified potential imprinting control regions regulating this novel cluster, suggesting a coordinated regulatory mechanism. Notably, these imprinted genes are enriched in cancer-related pathways, with several showing isoform-specific imprinting patterns. Our analysis also revealed consistent DNA methylation aberrations in pluripotent stem cells at specific imprinted loci, highlighting potential epigenetic instability during culturing. These findings contribute to our understanding of genomic imprinting regulation in human development and highlight potential genomic regions for further investigation of imprinting-related disorders.

Keywords

DNA methylation / epigenetics / genomic imprinting / human embryonic stem cells

References

[1] A. C. Ferguson-Smith, “Genomic Imprinting: The Emergence of an Epigenetic Paradigm,” Nature Reviews. Genetics 12, no. 8 (2011): 565–575, https://doi.org/10.1038/nrg3032.

[2] W. Reik and J. Walter, “Genomic Imprinting: Parental Influence on the Genome,” Nature Reviews. Genetics 2, no. 1 (2001): 21–32, https://doi.org/10.1038/35047554.

[3] D. Monk, D. J. G. Mackay, T. Eggermann, E. R. Maher, and A. Riccio, “Genomic Imprinting Disorders: Lessons on How Genome, Epigenome and Environment Interact,” Nature Reviews. Genetics 20, no. 4 (2019): 235–248, https://doi.org/10.1038/s41576-018-0092-0.

[4] J. Peters, “The Role of Genomic Imprinting in Biology and Disease: An Expanding View,” Nature Reviews. Genetics 15, no. 8 (2014): 517–530, https://doi.org/10.1038/nrg3766.

[5] A. P. Feinberg and B. Tycko, “The History of Cancer Epigenetics,” Nature Reviews. Cancer 4, no. 2 (2004): 143–153, https://doi.org/10.1038/nrc1279.

[6] Y. Stelzer, S. Bar, O. Bartok, et al., “Differentiation of Human Parthenogenetic Pluripotent Stem Cells Reveals Multiple Tissue- and Isoform-Specific Imprinted Transcripts,” Cell Reports 11, no. 2 (2015): 308–320, https://doi.org/10.1016/j.celrep.2015.03.023.

[7] I. M. Morison, C. J. Paton, and S. D. Cleverly, “The Imprinted Gene and Parent-of-Origin Effect Database,” Nucleic Acids Research 29, no. 1 (2001): 275–276, https://doi.org/10.1093/nar/29.1.275.

[8] S. Barbaux, G. Gascoin-Lachambre, C. Buffat, et al., “A Genome-Wide Approach Reveals Novel Imprinted Genes Expressed in the Human Placenta,” Epigenetics 7, no. 9 (2012): 1079–1090, https://doi.org/10.4161/EPI.21495.

[9] K. S. Pollard, D. Serre, X. Wang, et al., “A Genome-Wide Approach to Identifying Novel-Imprinted Genes,” Human Genetics 122, no. 6 (2008): 625–634, https://doi.org/10.1007/S00439-007-0440-1.

[10] L. Z. Strichman-Almashanu, R. S. Lee, P. O. Onyango, et al., “A Genome-Wide Screen for Normally Methylated Human Cpg Islands That Can Identify Novel Imprinted Genes,” Genome Research 12, no. 4 (2002): 543–554, https://doi.org/10.1101/GR.224102.

[11] S. Choufani, J. S. Shapiro, M. Susiarjo, et al., “A Novel Approach Identifies New Differentially Methylated Regions (DMRs) Associated With Imprinted Genes,” Genome Research 21, no. 3 (2011): 465–476, https://doi.org/10.1101/GR.111922.110.

[12] International Stem Cell Initiative, “Characterization of Human Embryonic Stem Cell Lines by the International Stem Cell Initiative,” Nature Biotechnology 25, no. 7 (2007): 803–816, https://doi.org/10.1038/nbt1318.

[13] S. Bar and N. Benvenisty, “Epigenetic Aberrations in Human Pluripotent Stem Cells,” EMBO Journal 38, no. 12 (2019): e101033, https://doi.org/10.15252/embj.2018101033.

[14] I. Sagi, G. Chia, T. Golan-Lev, et al., “Derivation and Differentiation of Haploid Human Embryonic Stem Cells,” Nature 532, no. 7597 (2016): 107–111, https://doi.org/10.1038/nature17408.

[15] Q. Mai, Y. Yu, T. Li, et al., “Derivation of Human Embryonic Stem Cell Lines From Parthenogenetic Blastocysts,” Cell Research 17, no. 12 (2007): 1008–1019, https://doi.org/10.1038/cr.2007.102.

[16] Y. Stelzer, O. Yanuka, and N. Benvenisty, “Global Analysis of Parental Imprinting in Human Parthenogenetic Induced Pluripotent Stem Cells,” Nature Structural & Molecular Biology 18, no. 6 (2011): 735–741, https://doi.org/10.1038/nsmb.2050.

[17] W. Li, L. Shuai, H. Wan, et al., “Androgenetic Haploid Embryonic Stem Cells Produce Live Transgenic Mice,” Nature 490, no. 7420 (2012): 407–411, https://doi.org/10.1038/nature11435.

[18] I. Sagi, J. C. De Pinho, M. V. Zuccaro, et al., “Distinct Imprinting Signatures and Biased Differentiation of Human Androgenetic and Parthenogenetic Embryonic Stem Cells,” Cell Stem Cell 25, no. 3 (2019): 419–432.e9, https://doi.org/10.1016/J.STEM.2019.06.013.

[19] L. Verrier, L. Davidson, M. Gierliński, A. Dady, and K. G. Storey, “Neural Differentiation, Selection and Transcriptomic Profiling of Human Neuromesodermal Progenitors-Like Cells in Vitro,” Development (Cambridge, England) 145, no. 16 (2018): dev166215, https://doi.org/10.1242/dev.166215.

[20] A. Meissner, A. Gnirke, G. W. Bell, B. Ramsahoye, E. S. Lander, and R. Jaenisch, “Reduced Representation Bisulfite Sequencing for Comparative High-Resolution DNA Methylation Analysis,” Nucleic Acids Research 33, no. 18 (2005): 5868–5877, https://doi.org/10.1093/NAR/GKI901.

[21] S. Bar, M. Schachter, T. Eldar-Geva, and N. Benvenisty, “Large-Scale Analysis of Loss of Imprinting in Human Pluripotent Stem Cells,” Cell Reports 19, no. 5 (2017): 957–968, https://doi.org/10.1016/j.celrep.2017.04.020.

[22] K. P. Kim, A. Thurston, C. Mummery, et al., “Gene-Specific Vulnerability to Imprinting Variability in Human Embryonic Stem Cell Lines,” Genome Research 17, no. 12 (2007): 1731–1742, https://doi.org/10.1101/GR.6609207.

[23] A. Gimelbrant, J. N. Hutchinson, B. R. Thompson, and A. Chess, “Widespread Monoallelic Expression on Human Autosomes,” Science 318, no. 5853 (2007): 1136–1140, https://doi.org/10.1126/SCIENCE.1148910.

[24] S. Choufani, C. Shuman, and R. Weksberg, “Beckwith-Wiedemann Syndrome,” American Journal of Medical Genetics. Part C, Seminars in Medical Genetics 154C, no. 3 (2010): 343–354, https://doi.org/10.1002/ajmg.c.30267.

[25] S. B. Cassidy, S. Schwartz, J. L. Miller, and D. J. Driscoll, “Prader-Willi syndrome,” Genetics in Medicine 14, no. 1 (2012): 10–26, https://doi.org/10.1038/GIM.0B013E31822BEAD0.

[26] L. Spahn and D. P. Barlow, “An ICE Pattern Crystallizes,” Nature Genetics 35, no. 1 (2003): 11–12, https://doi.org/10.1038/ng0903-11.

[27] I. M. Morison, J. P. Ramsay, and H. G. Spencer, “A Census of Mammalian Imprinting,” Trends in Genetics 21, no. 8 (2005): 457–465, https://doi.org/10.1016/J.TIG.2005.06.008.

[28] S. A. Carrion, J. J. Michal, and Z. Jiang, “Imprinted Genes: Genomic Conservation, Transcriptomic Dynamics and Phenomic Significance in Health and Diseases,” International Journal of Biological Sciences 19, no. 10 (2023): 3128–3142, https://doi.org/10.7150/IJBS.83712.

[29] R. L. Poole, D. J. Leith, L. E. Docherty, et al., “Beckwith–Wiedemann Syndrome Caused by Maternally Inherited Mutation of an OCT-Binding Motif in the IGF2/H19-Imprinting Control Region, ICR1,” European Journal of Human Genetics 20, no. 2 (2012): 240–243, https://doi.org/10.1038/ejhg.2011.166.

[30] P. Tannorella, D. Minervino, S. Guzzetti, et al., “Maternal Uniparental Disomy of Chromosome 20 (Upd(20)Mat) as Differential Diagnosis of Silver Russell Syndrome: Identification of Three New Cases,” Genes 12, no. 4 (2021): 588, https://doi.org/10.3390/GENES12040588/S1.

[31] Q. Huang, K. W. Choy, K. F. Cheung, D. Lam, W. L. Fu, and C. P. Pang, “Genetic Alterations on Chromosome 19, 20, 21, 22, and X Detected by Loss of Heterozygosity Analysis in Retinoblastoma,” Molecular Vision 9 (2003): 502–507.

[32] A. Bicher, K. Ault, A. Kimmelman, D. Gershenson, E. Reed, and B. Liang, “Loss of Heterozygosity in Human Ovarian Cancer on Chromosome 19q,” Gynecologic Oncology 66, no. 1 (1997): 36–40, https://doi.org/10.1006/GYNO.1997.4709.

[33] H. Li, B. Yang, K. Xing, et al., “A Preliminary Study of the Relationship Between Breast Cancer Metastasis and Loss of Heterozygosity by Using Exome Sequencing,” Scientific Reports 4, no. 1 (2014): 1–6, https://doi.org/10.1038/SREP05460.

[34] R. J. C. Kluin, K. Kemper, T. Kuilman, et al., “XenofilteR: Computational Deconvolution of Mouse and Human Reads in Tumor Xenograft Sequence Data,” BMC Bioinformatics 19, no. 1 (2018): 1–15, https://doi.org/10.1186/S12859-018-2353-5/FIGURES/6.

[35] A. Dobin, C. A. Davis, F. Schlesinger, et al., “STAR: Ultrafast Universal RNA-Seq Aligner,” Bioinformatics 29, no. 1 (2013): 15–21, https://doi.org/10.1093/bioinformatics/bts635.

[36] M. D. Robinson, D. J. McCarthy, and G. K. Smyth, “edgeR: A Bioconductor Package for Differential Expression Analysis of Digital Gene Expression Data,” Bioinformatics 26, no. 1 (2010): 139–140, https://doi.org/10.1093/bioinformatics/btp616.

[37] V. K. Mootha, C. M. Lindgren, K. F. Eriksson, et al., “PGC-1α-Responsive Genes Involved in Oxidative Phosphorylation Are Coordinately Downregulated in Human Diabetes,” Nature Genetics 34, no. 3 (2003): 267–273, https://doi.org/10.1038/ng1180.

[38] A. Subramanian, P. Tamayo, V. K. Mootha, et al., “Gene Set Enrichment Analysis: A Knowledge-Based Approach for Interpreting Genome-Wide Expression Profiles,” Proceedings of the National Academy of Sciences of the United States of America 102, no. 43 (2005): 15545–15550, https://doi.org/10.1073/PNAS.0506580102/SUPPL_FILE/06580FIG7.JPG.

[39] R. Sarel-Gallily, G. Keshet, S. Kinreich, G. Haim-Abadi, and N. Benvenisty, “EpiTyping: Analysis of Epigenetic Aberrations in Parental Imprinting and X-Chromosome Inactivation Using RNA-Seq,” Nature Protocols 18, no. 12 (2023): 3881–3917, https://doi.org/10.1038/S41596-023-00898-5.

[40] S. E. Castel, A. Levy-Moonshine, P. Mohammadi, E. Banks, and T. Lappalainen, “Tools and Best Practices for Data Processing in Allelic Expression Analysis,” Genome Biology 16, no. 1 (2015): 1–12, https://doi.org/10.1186/S13059-015-0762-6/FIGURES/7.

RIGHTS & PERMISSIONS

2025 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.